Xero shares (ASX:XRO) have just closed out the fourth consecutive week in the red, with Friday’s 2.81% drop to A$27.36 bringing with it a new seven year low at A$56.22. A four week decline that has now stretched to 33%, adds to a cumulative decline of 63.97% over the past 12 months, a tale of woe for XRO holders.
The latest move is a continuation of the trade in selling down tech stocks that are seen as having their previous ‘moats’ exposed to risk from AI platforms. Looking at similar names in the US market like Intuit, and the pattern on the chart is eerily similar in shape, albeit to a lower degree. Like Xero shares, after attempting to snap the selling pressure into mid August, both have gone into decline once again, with INTU also four weeks in the red, to the tune of 22.6%, with a TTM decline of 60%.
Treasury yields rising have put a dent in high growth names, and recent financials have not helped matters. Xero’s FY26 result revealed strong top-line growth that was overshadowed by a clear profit and margin wobble. Revenue rose 31% to NZ$2.75 billion and subscribers climbed 11% to 4.92 million, but net profit fell 27% to NZ$167.4 million and gross margin slipped from 89% toward 84%, weighed down by transaction and integration costs from the Melio acquisition and a larger mix of lower-margin payments revenue. Melio also pushed Xero from a net cash position into net debt, brought roughly NZ$52 million in one-off transaction costs, and was part-funded by a A$1.4 billion convertible notes issue, keeping balance-sheet questions front of mind.
With Australian 10-year yields around 5.3% and expectations of further Reserve Bank tightening, long-duration growth stocks are being repriced for a higher-for-longer rate world. Xero, with a beta of 2.24 versus the ASX 200, has consistently traded as a leveraged expression of tech risk appetite, falling harder than the broader IT sector on risk-off days.
Analysts Behind The Curve?
The gap between price and analyst price targets is extreme, with the average target of A$123.01 implying roughly 115% upside, with six buy or strong buy ratings, one hold and no sells across the major brokers. Even the most cautious voices on the stock carry targets 20% to 35% above the current price. The risk is that targets simply have not caught up with the market’s reset on margins and leverage, making potential downgrades a live watchpoint.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
The Setup
The technical setup is clearly bearish, with the RSI at 23.86 is deep in oversold territory, and the CCI reading around minus 111 confirming the downside stretch, a combination more consistent with capitulation-style selling and stop-loss triggers than orderly profit-taking. The trend itself is firmly established, with the ADX reading near 38 and rising pointing to a strong directional move, and the share price sits well below its 50-day average of A$73.81, which in turn sits below the 200-day average of A$81.77.
It is hard to think that just 1 month ago Xero had been in overbought territory (RSI at 76), and having broken above the 200 day SMA to test A$90. For XRO to stem the tide, some signs of margin stabilisation, or simply a pause in the rate-driven tech selling could see an oversold stock snap back. There are few signs of that taking place just now, hence the continued capitulation into the weekend.
Bull Case:
- Consensus target of A$123 implies roughly 115% upside, with no sell ratings.
- Revenue growing near 31%, subscribers up 11%, US payments opportunity intact.
- Deeply oversold technicals suggest capitulation selling, not fundamental collapse.
Bear Case:
- Profit fell 27%, margins slipped, and Melio shifted Xero into net debt.
- Entrenched downtrend with price below all key moving averages at multi-year lows.
- Rising yields and AI disruption fears keep pressuring long-duration software valuations.
